Psychiatric Pharmacogenomics: A Practical Guide to Gene-Drug Interactions and Tests
Pharmacogenomics (PGx) is the practice of using information about an individual’s genetic makeup, or genome, to select medications that are likely to be most effective and result in the fewest number of side effects for that particular patient. Michigan Medicine is an authoritative source on PGx scientifically and has conducted the world’s largest RCT on use of PGx in routine clinical practice for the treatment of depression.
This on-demand training course will introduce clinicians to the purpose and use of psychiatric PGx in order to enhance professional development and clinical performance, as well as to improve patient safety and outcomes. Each session is taught by a team of a key speaker and a moderator.
The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Michigan Medical School designates this live activity for a maximum of 5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.